^(89)SrCl_2在NSCLC多发性骨转移NP方案和介入治疗间期应用的临床研究

A Clinical Study on Strontium-89 Chloride Therapy for Bone Cancer Metastases in Interphase of NP Project or Interventional Therapy for NSCLC

目的 :研究NSCLC多发性骨转移应用89SrCl2 治疗的临床价值。方法 :在以NP方案和介入治疗NSCLC间期应用89SrCl2 治疗多发性骨转移。结果 :NP方案进行全身性化疗配合89SrCl2 治疗多发性骨转移组的有效率为92 .3% ,而介入治疗配合89SrCl2 治疗多发性骨转移组的 72 .7%。结论 :以NP方案进行全身性化疗配合89SrCl2 治疗多发性骨转移优于介入治疗配合89SrCl2

Objective:To study the value of Strontium-89 Chloride therapy for bone cancer metastases in NSCLC(non-cellule lung cancer).Methods Strontium-89 Chloride therapy was used for bone cancer metastases in interphase of NP project or interventional therapy for NSCLC.Results The of Strontium-89 Chloride therapy for bone cancer metastases in interphase of NP project had an effective rate of 92.3%,and the other group had an effective rate of 92.3% Conclusion Strontium-89 Chloride therapy for bone cancer metastases in interphase of NP project for NSCLC excells Strontium-89 Chloride therapy for cancer metastases in interphase of interventional therapy for NSCLC.